Cross-Neutralizing Anti-Chikungunya and Anti-Dengue 2 IgG Antibodies from Patients and BALB/c Mice against Dengue and Chikungunya Viruses
Authors:
- Araceli Posadas-MondragónAraceli Posadas-Mondragón
- José Angel Santiago-CruzJSJosé Angel Santiago-Cruz
- Angélica Pérez-JuárezAPAngélica Pérez-Juárez
- Norma Estela Herrera-GonzálezNHNorma Estela Herrera-González
- Sara M. Sosa-DelgadoSSSara M. Sosa-Delgado
- Claudia Elena Wong-ArámbulaCWClaudia Elena Wong-Arámbula
- Abril Paulina Rodríguez-MaldonadoARAbril Paulina Rodríguez-Maldonado
- Mauricio Vázquez-PichardoMVMauricio Vázquez-Pichardo
- Daniel Duran-AyalaDDDaniel Duran-Ayala
- José Leopoldo Aguilar-FaisalJAJosé Leopoldo Aguilar-Faisal
Open Access
Abstract
Dengue (DENV) and Chikungunya (CHIKV) viruses can be transmitted simultaneously by Aedes mosquitoes, and there may be co-infections in humans. However, how the adaptive immune response is modified in the host has yet to be known entirely. In this study, we analyzed the cross-reactivity and neutralizing activity of IgG antibodies against DENV and CHIKV in sera of patients from the Mexican Institute of Social Security in Veracruz, Mexico, collected in 2013 and 2015 and using IgG antibodies of BALB/c mice inoculated with DENV and/or CHIKV. Mice first inoculated with DENV and then with CHIKV produced IgG antibodies that neutralized both viruses. Mice were inoculated with CHIKV, and then with DENV; they had IgG antibodies with more significant anti-CHIKV IgG antibody neutralizing activity. However, the inoculation only with CHIKV resulted in better neutralization of DENV2. In sera obtained from patients in 2013, significant cross-reactivity and low anti-CHIKV IgG antibody neutralizing activity were observed. In CHIKV-positive 2015 sera, the anti-DENV IgG antibody neutralizing activity was high. These results suggest that CHIKV stimulates DENV2-induced memory responses and vice versa. Furthermore, cross-reactivity between the two viruses generated neutralizing antibodies, but exchanging CHIKV for DENV2 generated a better anti-CHIKV neutralizing response.Keywords
Funding Information
- SECRETARÍA DE INVESTIGACIÓN Y POSGRADO from INSTITUTO POLITÉCNICO NACIONAL (SIP-20201870, CBF2023-2024-2199)
- Consejo Nacional de Humanidades, Ciencia y Tecnologías (CONAHCyT) (SIP-20201870, CBF2023-2024-2199)
This publication has 38 references indexed in Scilit:
- DengueThe Lancet, 2024
- Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from IndiaArchives of Virology, 2021
- Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohortInternational Journal of Infectious Diseases, 2020
- The continued threat of emerging flavivirusesNature Microbiology, 2020
- Flavivirus infection—A review of immunopathogenesis, immunological response, and immunodiagnosisVirus Research, 2019
- A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activationJournal of Immunological Methods, 2019
- Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictusNature Microbiology, 2019
- Impact of simultaneous exposure to arboviruses on infection and transmission by Aedes aegypti mosquitoesNature Communications, 2017
- High rates of co-infection of Dengue and Chikungunya virus in Odisha and Maharashtra, India during 2013Infection, Genetics and Evolution, 2015
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyVirology, 2009